Latest Capital Markets News

Page 12 of 162
Spenda Limited's SPXOB securities have been suspended from trading by the ASX due to non-compliance with listing requirements. The suspension affects only this security class, leaving other Spenda securities unaffected.
Claire Turing
Claire Turing
2 July 2026
Qoria Limited and Aura Consolidated Group have fixed the exchange ratio for their proposed merger, with shareholders to receive one Aura CDI for every 17.32 Qoria shares. Aura’s US$100 million capital raise values Qoria shares at A$0.40 each, positioning Qoria shareholders to hold nearly a third of the merged entity.
Sophie Babbage
Sophie Babbage
2 July 2026
Pan African Resources has completed the issuance of over 102 million new shares to Emmerson shareholders, marking the formal close of its acquisition via a scheme of arrangement.
Maxwell Dee
Maxwell Dee
2 July 2026
Javelin Minerals has replaced milestone shares with performance rights as part of its Central Yilgarn acquisition, capping potential dilution with a floor price mechanism.
Maxwell Dee
Maxwell Dee
1 July 2026
Magellan Financial Group has finalised its merger with Barrenjoey Capital Partners, forming a diversified financial services group poised to rebrand as Barrenjoey Group Limited. The combined entity appoints Brian Benari as CEO and David Gonski AC as Chairman, signalling a strategic expansion across investment management, financial markets, and corporate finance.
Claire Turing
Claire Turing
1 July 2026
Lendlease has partnered with The Crown Estate to form the Impact Partnership Joint Venture, unlocking a £24 billion UK development pipeline including up to 30,000 new homes and nearly a million square metres of office and life sciences space.
Eva Park
Eva Park
1 July 2026
Recce Pharmaceuticals has received a significant A$3.7 million income tax refund from the Australian Taxation Office, strengthening its cash position to approximately A$33.1 million as it prepares for critical Phase 3 clinical milestones.
Ada Torres
Ada Torres
1 July 2026
Chimeric Therapeutics has appointed Hawkesbury Partners to lead a strategic review aimed at exploring options to enhance shareholder value, reflecting concerns that its market cap undervalues its clinical assets and infrastructure.
Ada Torres
Ada Torres
1 July 2026
Albright Metals has completed its second staged payment milestone for the Golden Pike Gold and Antimony Project, issuing shares and cash to Globex Mining Enterprises as exploration and development progress.
Maxwell Dee
Maxwell Dee
30 June 2026
Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.
Sophie Babbage
Sophie Babbage
30 June 2026
Resouro Strategic Metals has unveiled a robust Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project, signalling a post-tax NPV of US$715 million and a 44.2% IRR over 20 years. Meanwhile, binding agreements for mining and processing at the Novo Mundo Gold Project promise to unlock additional value.
Maxwell Dee
Maxwell Dee
30 June 2026
Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.
Maxwell Dee
Maxwell Dee
30 June 2026

Browse the archive

Full archive